miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 11, 142-158
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81325013)
- National Natural Science Foundation of China (81530082)
- National Natural Science Foundation of China (81773106)
- National Natural Science Foundation of China (91529301)
- National Natural Science Foundation of China (91740118)
This publication has 56 references indexed in Scilit:
- The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to boneBritish Journal of Cancer, 2017
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceNature, 2015
- Treatment of metastatic pancreatic adenocarcinoma: a review.2014
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine ActivityCancer Research, 2010
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic CancerPLOS ONE, 2010
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer CellsCancer Research, 2009
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cellsBlood, 2006
- Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesisGastroenterology, 2002
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001